Concentrix (NASDAQ:CNXC – Get Free Report) issued an update on its FY 2026 earnings guidance on Monday morning. The company provided EPS guidance of 10.830-11.180 for the period, compared to the consensus earnings per share estimate of 11.450. The company issued revenue guidance of $9.9 billion-$10.0 billion, compared to the consensus revenue estimate of $10.1 billion. Concentrix also updated its Q3 2026 guidance to 2.650-2.770 EPS.
Analyst Ratings Changes
Several equities analysts recently commented on the stock. Wall Street Zen lowered shares of Concentrix from a “buy” rating to a “hold” rating in a research report on Saturday, March 28th. Barrington Research cut their target price on shares of Concentrix from $38.00 to $30.00 and set an “outperform” rating on the stock in a research note on Tuesday. Canaccord Genuity Group lowered their price target on Concentrix from $55.00 to $45.00 and set a “buy” rating for the company in a report on Tuesday. Weiss Ratings restated a “sell (d)” rating on shares of Concentrix in a research note on Monday, April 27th. Finally, Robert W. Baird lowered their target price on Concentrix from $40.00 to $30.00 and set an “outperform” rating for the company in a research note on Tuesday. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Concentrix presently has a consensus rating of “Hold” and an average target price of $32.75.
Check Out Our Latest Stock Analysis on Concentrix
Concentrix Stock Down 11.2%
Concentrix (NASDAQ:CNXC – Get Free Report) last issued its earnings results on Monday, June 29th. The company reported $2.63 earnings per share for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). Concentrix had a positive return on equity of 18.93% and a negative net margin of 13.16%.The business had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.47 billion. During the same period last year, the company posted $2.70 earnings per share. The firm’s revenue for the quarter was up 1.9% on a year-over-year basis. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. Sell-side analysts predict that Concentrix will post 10.42 EPS for the current fiscal year.
Concentrix Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, August 4th. Shareholders of record on Friday, July 24th will be paid a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 6.4%. The ex-dividend date is Friday, July 24th. Concentrix’s payout ratio is presently -6.68%.
Insider Activity at Concentrix
In related news, CFO Andre S. Valentine purchased 2,500 shares of the business’s stock in a transaction that occurred on Thursday, April 9th. The shares were acquired at an average price of $27.95 per share, with a total value of $69,875.00. Following the acquisition, the chief financial officer owned 89,066 shares in the company, valued at approximately $2,489,394.70. This trade represents a 2.89% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 29th. The shares were sold at an average price of $22.25, for a total value of $133,500,000.00. Following the transaction, the insider owned 2,773,667 shares of the company’s stock, valued at $61,714,090.75. This represents a 68.39% decrease in their position. The SEC filing for this sale provides additional information. 0.90% of the stock is currently owned by corporate insiders.
Trending Headlines about Concentrix
Here are the key news stories impacting Concentrix this week:
- Positive Sentiment: Concentrix reported record second-quarter cash flow from operations of $258 million and adjusted free cash flow of $242 million, and management said iX Suite deals rose 400% year over year, signaling progress in its AI and software-related growth efforts.
- Positive Sentiment: Several analysts still see upside despite trimming targets: Barrington Research and Robert W. Baird both reiterated outperform ratings while cutting price targets to $30, and Canaccord Genuity kept a bullish stance even after lowering its forecast.
- Neutral Sentiment: The company declared a quarterly dividend of $0.36 per share, which implies a 5.7% annualized yield and may help support investor interest.
- Negative Sentiment: Q2 adjusted EPS of $2.63 missed the $2.64 consensus estimate, and revenue of $2.46 billion came in slightly below expectations, reinforcing concerns that growth is slowing.
- Negative Sentiment: Management also cut FY2026 and Q3 guidance below Wall Street forecasts, citing clients trimming spend; that downgrade to the outlook is the main reason the stock is under pressure.
- Negative Sentiment: Analysts and market commentary pointed to margin pressure, weaker cash generation in some measures, and leverage concerns, which are adding to the selloff in CNXC shares.
Hedge Funds Weigh In On Concentrix
Several hedge funds and other institutional investors have recently modified their holdings of CNXC. AQR Capital Management LLC grew its position in shares of Concentrix by 1.8% during the third quarter. AQR Capital Management LLC now owns 4,380,821 shares of the company’s stock worth $202,175,000 after acquiring an additional 75,352 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Concentrix by 28.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,491,270 shares of the company’s stock valued at $103,588,000 after purchasing an additional 551,778 shares during the last quarter. State Street Corp boosted its stake in Concentrix by 8.7% during the 2nd quarter. State Street Corp now owns 1,622,854 shares of the company’s stock valued at $85,776,000 after purchasing an additional 130,529 shares during the period. First Trust Advisors LP grew its position in Concentrix by 37.7% in the 4th quarter. First Trust Advisors LP now owns 805,898 shares of the company’s stock worth $33,509,000 after purchasing an additional 220,590 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its position in Concentrix by 157.1% in the 4th quarter. Bank of New York Mellon Corp now owns 709,770 shares of the company’s stock worth $29,512,000 after purchasing an additional 433,731 shares during the last quarter. Institutional investors and hedge funds own 90.34% of the company’s stock.
Concentrix Company Profile
Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Featured Articles
- Five stocks we like better than Concentrix
- Short Squeeze Alert—Moderna Stock Surges on New Strategy
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.
